Bioequivalence studies: Inspections and regulators' expectations
Solutions OP Clinical Trials UK por Olga Peycheva
Notas del episodio
Our latest podcast is dedicated to bioequivalence studies and their specific challenges. We also cover what was discussed in terms of inspection findings, cases studies and expectations by FDA and Health Canada on their recent symposium in June 2026. In addition, Lydia Ainsworth, shares with us her practical experience from site level and monitoring level on common issues with blood sample collections.
Palabras clave
clinical trialsGCPclinical trials set upGCP inspectionBioequivalence studiespharmacokinetics samples